Mitsubishi Tanabe Pharma Corp operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mitsubishi Tanabe Pharma Corp with three other
companies in this sector in Japan:
Shionogi & Co Ltd
sales of 309.97 billion Japanese Yen [US$2.98 billion]
of which 100%
Taisho Pharmaceutical Holdings Co Ltd
(290.14 billion Japanese Yen [US$2.79 billion]
of which 62%
was Self-medication), and
Eisai Company Limited
(547.92 billion Japanese Yen [US$5.26 billion]
of which 49%
was Pharmaceutical Business -Japan).
During the year ended March of 2016, sales at
Mitsubishi Tanabe Pharma Corp were ¥431.70 billion (US$4.14 billion).
increase of 4.0%
versus 2015, when the company's sales were ¥415.12 billion.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Mitsubishi Tanabe Pharma Corp had sales
of ¥409.54 billion.